Why an ovary syndrome may get a new name: Men seem to have PCOS, too - Report - MDSpire

Why an ovary syndrome may get a new name: Men seem to have PCOS, too

  • By

  • Annalisa Merelli

  • April 1, 2026

  • 0 min

Share

Clinical Report: Reevaluating Polycystic Ovary Syndrome in Male Health

Overview

This report explores the implications of polycystic ovary syndrome (PCOS) beyond female health, suggesting a potential male counterpart characterized by low androgen levels and metabolic issues. The traditional understanding of PCOS is being challenged, with calls for a name change to better reflect its complexity.

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting 10-13% of women, associated with significant reproductive and metabolic health risks. The condition often goes undiagnosed, leading to long-term health implications such as diabetes and cardiovascular disease. Recent discussions suggest that the characteristics of PCOS may also manifest in males, prompting a reevaluation of the syndrome's nomenclature and diagnostic criteria.

Data Highlights

No numerical data available in the source material.

Key Findings

  • PCOS affects up to 13% of reproductive-age women, with many cases undiagnosed.
  • Symptoms include weight gain, acne, hirsutism, and mental health issues.
  • Diagnosis requires two of three criteria: ovulatory dysfunction, androgen excess, and polycystic ovarian morphology.
  • Overdiagnosis occurs due to the commonality of polycystic morphology, which does not always indicate PCOS.
  • There is growing evidence suggesting a male version of PCOS characterized by low androgen levels and metabolic issues.

Clinical Implications

Healthcare professionals should consider the broader implications of PCOS and its potential manifestations in males. A reevaluation of diagnostic criteria and nomenclature may enhance understanding and management of related metabolic and psychological issues in both genders.

Conclusion

The evolving understanding of PCOS highlights the need for a more inclusive approach to diagnosis and treatment, recognizing its potential impact on male health as well.

References

  1. Yıldız O.B., The Journal of Clinical Endocrinology & Metabolism, 2023 -- Evaluating Patients: Navigating Diagnostic Obstacles in Polycystic Ovary Syndrome Assessment
  2. Zhao X., The Journal of Clinical Endocrinology & Metabolism, 2023 -- The Quest for Identifying Polycystic Ovary Syndrome
  3. European Journal of Preventive Cardiology, 2023 -- Addressing Polycystic Ovary Syndrome to Mitigate Cardiovascular Disease Risk
  4. European Journal of Preventive Cardiology, 2023 -- Nonobese young females with polycystic ovary syndrome are at high risk for long-term cardiovascular disease

Original Source(s)

Related Content